FDA Inspection
RedPharm DrugFDA Inspection 1030658 - RedPharm Drug - November 03, 2017
Record Details
This FDA Inspection record concerns RedPharm Drug, with an inspection on November 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- RedPharm Drug
- Inspection Date
- November 3, 2017
- Product Type
- Drugs
View Company Profile
ID · a0e67f75-cfe4-467a-9b1a-eeb4b0d2a23e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1030658
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RedPharm Drug
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| September 11, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 29, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RedPharm Drug
- FDA Inspection 1277212 - 2025-08-01
- FDA Inspection 848068 - 2013-09-11
- FDA Inspection 636090 - 2009-12-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.